Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (71-80 of 337) with videos related to

Pageof 34
Sort By:
Frontiers in Oncology|January 4, 2021
Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered RosettesLisa Mayr, Johannes Gojo, Andreas Peyrl, et al.
Journal of Neuro-Oncology|March 31, 2015
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomasEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Plos One|June 19, 2013
Coverage bias and sensitivity of variant calling for four whole-genome sequencing technologiesNora Rieber, Marc Zapatka, Bärbel Lasitschka, et al.
Acta Neuropathologica|March 24, 2018
Molecular characterization of medulloblastomas with extensive nodularity (MBEN)Andrey Korshunov, Felix Sahm, Damian Stichel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic featuresPablo Tamayo, Yoon-Jae Cho, Aviad Tsherniak, et al.
BMC Cancer|June 13, 2019
Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastomaAe Kyung Park, Ji Yeoun Lee, Heesun Cheong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expressionTalitha de Haas, Nancy Hasselt, Dirk Troost, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 2005
Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE librariesGerben J Schaaf, Jan M Ruijter, Fred van Ruissen, et al.
Developmental Cell|September 30, 2014
The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumorsFrédéric Mille, Lukas Tamayo-Orrego, Martin Lévesque, et al.
Acta Neuropathologica|June 30, 2022
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expressionAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Pageof 34

Showing results (71-80 of 337) with videos related to

Sort By:
Pageof 34
Frontiers in Oncology|January 4, 2021
Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered RosettesLisa Mayr, Johannes Gojo, Andreas Peyrl, et al.
Journal of Neuro-Oncology|March 31, 2015
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomasEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Plos One|June 19, 2013
Coverage bias and sensitivity of variant calling for four whole-genome sequencing technologiesNora Rieber, Marc Zapatka, Bärbel Lasitschka, et al.
Acta Neuropathologica|March 24, 2018
Molecular characterization of medulloblastomas with extensive nodularity (MBEN)Andrey Korshunov, Felix Sahm, Damian Stichel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic featuresPablo Tamayo, Yoon-Jae Cho, Aviad Tsherniak, et al.
BMC Cancer|June 13, 2019
Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastomaAe Kyung Park, Ji Yeoun Lee, Heesun Cheong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expressionTalitha de Haas, Nancy Hasselt, Dirk Troost, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 2005
Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE librariesGerben J Schaaf, Jan M Ruijter, Fred van Ruissen, et al.
Developmental Cell|September 30, 2014
The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumorsFrédéric Mille, Lukas Tamayo-Orrego, Martin Lévesque, et al.
Acta Neuropathologica|June 30, 2022
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expressionAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Pageof 34